Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Helen F. Graham Cancer Center
& Research Institute

Hepatobiliary and Pancreatic Cancer

The Helen F. Graham Cancer Center & Research Institute’s Hepatobiliary and Pancreatic Cancer Multidisciplinary Center specializes in treating cancers of the:

  • Liver.
  • Pancreas.
  • Digestive or gastrointestinal tract.

Your multidisciplinary team

Surgery, chemotherapy and radiation are used to treat these cancers. Decades of clinical experience show that combinations of these treatments often are most effective. Your team will tailor your cancer treatment for your cancer and for you.

Advances in interventional radiology make it possible to destroy cancer tumors with drugs that specifically target tumor cells (chemoembolization) or with tiny sources of radiation that are implanted directly into the tumor. A new treatment for liver cancer, called radiofrequency ablation, uses heat produced by electrical current to kill cancer cells.

When you visit the Helen F. Graham Cancer Center & Research Institute, you will meet with a team of doctors in one visit:

  • Your surgeon can order diagnostic tests, perform a biopsy to see if your tumor is malignant or operate to remove cancer if necessary.
  • Your medical oncologist can administer chemotherapy or immunotherapy that kills cancer cells.
  • Your radiation oncologist can pinpoint places where your cancer is growing and use precisely focused X-rays to reduce or destroy it.
  • A vascular/interventional radiologist who can destroy solid tumors with new, minimally invasive techniques.

Together, these specialists, in consultation with your primary-care doctor and with the support of your care-management team, will work with you to create the most appropriate and effective plan of treatment for your cancer.

Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
302-623-4500